Chemotherapy-induced peripheral neuropathy: clinical features, diagnosis, prevention and treatment strategies
Clin. transl. oncol. (Print)
; 12(2): 81-91, feb. 2010. tab, ilus
Article
in English
| IBECS
| ID: ibc-123891
Responsible library:
ES1.1
Localization: BNCS
ABSTRACT
Chemotherapy-induced peripheral neuropathy (CIN) is a common toxicity of anticancer treatment and its incidence is growing. It significantly affects quality of life and is a dose-limiting factor that interferes with treatment. Its diagnosis can be established in clinical terms but some complementary tests can help when the diagnosis is difficult. There is still no proven method to prevent it that has become a standard of care in spite of the huge amount of investigation carried out in recent years. There are promising strategies that could help reduce the burden of this complication. This review will suggest an approach to the diagnosis of these disorders and provide an update on new therapies (AU)
Search on Google
Collection:
National databases
/
Spain
Health context:
Sustainable Health Agenda for the Americas
Health problem:
Goal 9: Noncommunicable diseases and mental health
Database:
IBECS
Main subject:
Antineoplastic Combined Chemotherapy Protocols
/
Peripheral Nervous System Diseases
Type of study:
Diagnostic study
/
Evaluation study
Aspects:
Patient-preference
Limits:
Animals
/
Female
/
Humans
/
Male
Language:
English
Journal:
Clin. transl. oncol. (Print)
Year:
2010
Document type:
Article
Institution/Affiliation country:
Hospital Univeristario 12 de Octubre/Spain
/
Infanta Sofía Hospital/Spain